Seattle Genetics, Celltech In $30M Antibody Conjugate Deal March 29, 2002 By Karen Young No Comments Celltech Group plc and Seattle Genetics Inc. entered into a multiyear research collaboration to use Seattle Genetics’ antibody-drug conjugate technology with Celltech’s antibody fragments, initially for immunological targets. (BioWorld Today)Read More
Aphton Sells 1.2M Shares, Raises $12.6M For Trials, Operations March 25, 2002 By Karen Young No Comments
Aphton Sells 1.2M Shares, Raises $12.6M For Trials, Operations March 25, 2002 By Karen Young No Comments
Cell Genesys Drops Gene Therapy Collaboration With GPC Biotech March 22, 2002 By Karen Young No Comments
Hemosol’s Stock Falls 29 Percent After Hemolink Denial In Canada March 22, 2002 By Karen Young No Comments
Cell Genesys Drops Gene Therapy Collaboration With GPC Biotech March 22, 2002 By Karen Young No Comments
